Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01829139
Other study ID # SCH-MULTI
Secondary ID
Status Recruiting
Phase N/A
First received April 4, 2013
Last updated April 8, 2013
Start date March 2012
Est. completion date December 2021

Study information

Verified date April 2013
Source Soon Chun Hyang University
Contact Tae Hoon Lee, MD, PhD
Phone +82-41-570-3662
Email thlee9@schmc.ac.kr
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Observational [Patient Registry]

Clinical Trial Summary

In patients with gallbladder in situ after complete removal of common bile duct (CBD) stones, there is no definite guideline for the management of remnant acalculous gallbladder. This study was planned to evaluate the efficacy of choleretic agents in those patients comparing with non-treatment group during short (2 years) and long-term (5 to 10 years) period. So that, the investigators want to establish the treatment guideline in gallbladder in situ without definite stones following complete removal of CBD stones. Second, the protective or preventive effect of choleretics may be defined.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 2021
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Complete clearance of CBD stones

- No definite GB stones

- Agree with the study protocol

Exclusion Criteria:

- < 18 years of age

- Concomitant IHD stones

- Combined malignancy with a limted life span

- Prior cholecystectomy state

- refusal to agree to the study protocol

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Locations

Country Name City State
Korea, Republic of Soon Chun Hyang University Cheonan Hospital Cheonan Chungcheongnam-do

Sponsors (1)

Lead Sponsor Collaborator
Soon Chun Hyang University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other Drug-related adverse event Other outcome measure includes adverse events after choleretics. three months No
Primary Complications The primary outcome is biliary complications between two groups during follow-up. two year No
Secondary Natural outcomes Other outcome measures included adverse events after choleretics and natural clinical courses of gallbladder in situ. two year No
Secondary Other adverse events Other outcome measures included adverse events after choleretics and natural outcomes of gallbladder in situ. two year No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02958618 - The Effect of Different Duration of Bolloon Dilation During ESBD N/A
Completed NCT02497872 - Early Precut Versus Pancreatic Stent for Post-ERCP Pancreatitis N/A
Recruiting NCT02144493 - Risk Factors for Recurrence of Primary Bile Duct Stones N/A
Completed NCT00852072 - Randomized Trial for Extraction of Difficult Bile Duct Stones N/A
Completed NCT00806780 - Role of Routine on-Table Cholangiography in Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT05381064 - Effect of a Deep Learning-based Bile Duct Scanning System on the Diagnostic Accuracy of Common Bile Duct Stones During Examination by Novice Ultrasound Endoscopists N/A
Withdrawn NCT02776709 - Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass)
Completed NCT02155244 - Common Bile Duct Stone Management: What Have we Learned? N/A
Completed NCT00807729 - Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely Choledocholithiasis N/A
Completed NCT02666820 - Endoscopic Papillary Large Balloon Dilatation Versus Mechanical Lithotripsy for Large Stones N/A